June 27, 2024   Sweden
G&W Fondkomission: presentation av delårsrapport III
Diamyd Medicals vd Ulf Hannelius presenterar bolagets delårsrapport III och nuvarande status med anledning av rapporten som publicerades den 26 juni.

Producerat i samarbete med G&W Fondkomission.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS